Effects of anti-vascular endothelial growth factor monoclonal antibody (bevacizumab) on lens epithelial cells

References

• McNultyRWangHMathiasRTOrtwerthBJTruscottRJBassnettSRegulation of tissue oxygen levels in the mammalian lensJ Physiol2004559pt 388389815272034
   PubMed Web of Science ®Google Scholar
• NeelamSBrooksMMCammarataPRLenticular cytoprotection. Part 1: the role of hypoxia inducible factors-1alpha and -2alpha and vascular endothelial growth factor in lens epithelial cell survival in hypoxiaMol Vis20131911523335846
   PubMed Web of Science ®Google Scholar
• ShuiYBWangXHuJSVascular endothelial growth factor expression and signaling in the lensInvest Ophthalmol Vis Sci20034493911391912939309
   PubMed Web of Science ®Google Scholar
• Saint-GeniezMKuriharaTD’AmorePARole of cell and matrix-bound VEGF isoforms in lens developmentInvest Ophthalmol Vis Sci200950131132118757513
   PubMed Web of Science ®Google Scholar
• PennockSKimDMukaiSRanibizumab is a potential prophylaxis for proliferative vitreoretinopathy, a nonangiogenic blinding diseaseAm J Pathol201318251659167023582767
   PubMed Web of Science ®Google Scholar
• Casaroli-MaranoRPPaganRVilaroSEpithelial-mesenchymal transition in proliferative vitreoretinopathy: intermediate filament protein expression in retinal pigment epithelial cellsInvest Ophthalmol Vis Sci19994092062207210440262
   PubMed Web of Science ®Google Scholar
• KimTIChungJLHongJPMinKSeoKYKimEKBevacizumab application delays epithelial healing in rabbit corneaInvest Ophthalmol Vis Sci200950104653465919458331
   PubMed Web of Science ®Google Scholar
• KimECRyuHWLeeHJKimMSBevacizumab eye drops delay corneal epithelial wound healing and increase the stromal response to epithelial injury in ratsClin Experiment Ophthalmol201341769470123433183
   PubMed Web of Science ®Google Scholar
• LeeSHLeemHSJeongSMLeeKBevacizumab accelerates corneal wound healing by inhibiting TGF-beta2 expression in alkali-burned mouse corneaBMB Rep2009421280080520044951
   PubMed Web of Science ®Google Scholar
• SinapisCIRoutsiasJGSinapisAIPharmacokinetics of intravitreal bevacizumab (Avastin®) in rabbitsClin Ophthalmol2011569770421629577
   PubMedGoogle Scholar
• KastnerCLoblerMReskeTSternbergKGuthoffRSchmitzKPDetermination of human anterior lens capsule permeability for fluorescent model substances and after-cataract preventive drugsBiomed Eng201257561563
   Google Scholar
• KastnerCLoblerMSternbergKPermeability of the anterior lens capsule for large molecules and small drugsCurr Eye Res201338101057106323885713
   PubMed Web of Science ®Google Scholar
• BakriSJSnyderMRReidJMPulidoJSSinghRJPharmacokinetics of intravitreal bevacizumab (Avastin)Ophthalmology2007114585585917467524
   PubMed Web of Science ®Google Scholar
• NomotoHShiragaFKunoNPharmacokinetics of bevacizumab after topical, subconjunctival, and intravitreal administration in rabbitsInvest Ophthalmol Vis Sci200950104807481319324856
   PubMed Web of Science ®Google Scholar
• JunJHSohnWJLeeYChangSDKimJYExperimental lens capsular bag model for posterior capsule opacificationCell Tissue Res2014357110110824793776
   PubMed Web of Science ®Google Scholar
• SymondsJGLovicuFJChamberlainCGPosterior capsule opacification-like changes in rat lens explants cultured with TGFbeta and FGF: effects of cell coverage and regional differencesExp Eye Res200682469369916359663
   PubMed Web of Science ®Google Scholar
• FerraraNHillanKJNovotnyWBevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapyBiochem Biophys Res Commun2005333232833515961063
   PubMed Web of Science ®Google Scholar
• DeStafenoJJKimTTopical bevacizumab therapy for corneal neovascularizationArch Ophthalmol2007125683483617562998
   PubMedGoogle Scholar
• KimSWHaBJKimEKTchahHKimTIThe effect of topical bevacizumab on corneal neovascularizationOphthalmology20081156e33e3818439681
   PubMedGoogle Scholar
• Nava-CastanedaAOlvera-MoralesORamos-CastellonCGarnica-HayashiLGarfiasYRandomized controlled trial of conjunctival autografting combined with subconjunctival bevacizumab for primary pterygium treatment: one year follow-upClin Experiment Ophthalmol201442323524123777441
   PubMed Web of Science ®Google Scholar
• HosseiniHNejabatMMehryarMYazdchiTSedaghatANooriFBevacizumab inhibits corneal neovascularization in an alkali burn induced model of corneal angiogenesisClin Experiment Ophthalmol200735874574817997779
   PubMed Web of Science ®Google Scholar
• SaracODemirelSOltuluREfficacy of intralesional bevacizumab administration in primary pterygium: a quantitative analysisEye Contact Lens2014401465024335454
   PubMed Web of Science ®Google Scholar
• KusakaSShimaCWadaKEfficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot studyBr J Ophthalmol200892111450145518621796
   PubMed Web of Science ®Google Scholar
• DastjerdiMHSabanDROkanoboAEffects of topical and subconjunctival bevacizumab in high-risk corneal transplant survivalInvest Ophthalmol Vis Sci20105152411241719892863
   PubMed Web of Science ®Google Scholar
• ChoKJChoiJSChoiMYJooCKEffects of subconjunctival ranibizumab in a presensitized rat model of corneal graftExp Eye Res2013107747923220731
   PubMed Web of Science ®Google Scholar
• CursiefenCCaoJChenLInhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survivalInvest Ophthalmol Vis Sci20044582666267315277490
   PubMed Web of Science ®Google Scholar
• ChalamKVAgarwalSBrarVSMurthyRKSharmaRKEvaluation of cytotoxic effects of bevacizumab on human corneal cellsCornea200928332833319387236
   PubMed Web of Science ®Google Scholar
• RusoviciRSakhalkarMChalamKVEvaluation of cytotoxicity of bevacizumab on VEGF-enriched corneal endothelial cellsMol Vis2011173339334622219629
   PubMed Web of Science ®Google Scholar
• IandievIFranckeMMakarovFEffects of intravitreal bevacizumab (Avastin) on the porcine retinaGraefes Arch Clin Exp Ophthalmol2011249121821182921845390
   PubMed Web of Science ®Google Scholar
• Zayit-SoudrySZemelEBarakAPerlmanILoewensteinASafety of intravitreal bevacizumab in the developing rabbit retinaRetina20113191885189521799464
   PubMed Web of Science ®Google Scholar
• ChenCLLiangCMChenYHTaiMCLuDWChenJTBevacizumab modulates epithelial-to-mesenchymal transition in the retinal pigment epithelial cells via connective tissue growth factor up-regulationActa Ophthalmol2012905e389e39822712616
   PubMed Web of Science ®Google Scholar
• ForooghianFKertesPJEngKTAgronEChewEYAlterations in the intraocular cytokine milieu after intravitreal bevacizumabInvest Ophthalmol Vis Sci20105152388239220007836
   PubMed Web of Science ®Google Scholar
• NakaoSIshikawaKYoshidaSAltered vascular microenvironment by bevacizumab in diabetic fibrovascular membraneRetina201333595796323503340
   PubMed Web of Science ®Google Scholar